Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) shares were down 0.9% during mid-day trading on Thursday . The stock traded as low as $3.36 and last traded at $3.42. Approximately 616,192 shares were traded during mid-day trading, a decline of 12% from the average daily volume of 700,769 shares. The stock had previously closed at $3.45.
Ono Pharmaceutical Stock Down 0.9 %
The company has a 50 day moving average of $3.61 and a 200-day moving average of $4.25.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Election Stocks: How Elections Affect the Stock Market
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20220915161652&h=45&w=95&zc=2){kind=logo}
